Striae Cream with Regenetrol Complex(TM) Demonstrates Efficacy on Stretch Marks: A Double-Blind Controlled Study

Main Article Content

Stephanie Moy
Independent

Lawrence S Moy
Timothy Lesser

Keywords

Striae, regenetrol, stretch marks

Abstract

This article reviews the efficacy of the first product that is specifically devoted to treating stretch marks. Stretch marks previously have been considered an untreatable cosmetic problem. Striae Cream with the Regenetrol ComplexTM was studied in a double-blind controlled format in which the cream applied to one side of the body was compared with the control cream applied to the other side of the body after two months. The results demonstrate that 80% of the patients tested benefited from using the cream and 35% had marked clearing. Results could be seen within 4 weeks. The cream was successful for treating the ridging, redness, and whiteness associated with the stretch marks. Additionally, older and thicker stretchmarks demonstrated improvement with Regenetrol ComplexTM application.

References

Black, Martin M., Christina M. Ambros-Rudolph, Libby Edwards, and Peter J. Lynch. "Ch 3: Physiologic Skin Changes of Pregnancy."Obstetric and Gynecologic Dermatology. London: Mosby, 2008. 24. Print.

Dover, J., Rothaus, K., & Gold, M. (2014). Evaluation of safety and patient subjective efficacy of using radiofrequency and pulsed magnetic fields for the treatment of striae (stretch marks). J Clin Aesthet Dermatol. Retrieved June 17, 2015, from http://www.ncbi.nlm.nih.gov/pubmed/25276274

Hexsel, D., Soirefmann, M., Porto, M., Schilling-Souza, J., Siega, C., & Dalʼforno, T. (2014). Superficial Dermabrasion Versus Topical Tretinoin on Early Striae Distensae: A Randomized, Pilot Study. Dermatologic Surgery,537-544.

Korgavkar, K., & Wang, F. (2015). Stretch marks during pregnancy: A review of topical prevention. Br J Dermatol British Journal of Dermatology,606-615.

Mcavoy, B. (2013). No evidence for topical preparations in preventing stretch marks in pregnancy. Br J Gen Pract British Journal of General Practice, 212-212.

Moore, J., Kelsberg, G., & Saphranek, S. (2012). Clinical Inquiry: Do any topical agents help prevent or reduce stretch marks? J Fam Pract.Retrieved June 17, 2015, from http://www.ncbi.nlm.nih.gov/pubmed/23313995

Otman, Haley. "Stretch Mark Science: What Happens to Your Skin When Pregnancy Gives You a Stretch Mark?" University of Michigan. University of Michigan, Health System, 17 Nov. 2015. Web. 12 May 2016.

Ryu, H., Kim, S., Jung, H., Ryoo, Y., Lee, K., & Cho, J. (2013). Clinical Improvement of Striae Distensae in Korean Patients Using a Combination of Fractionated Microneedle Radiofrequency and Fractional Carbon Dioxide Laser. Dermatologic Surgery Dermatol Surg.
Sardana, K. (2014). Lasers for treating striae: An emergent need for better evidence. Indian J Dermatol Venereol Leprol Indian Journal of Dermatology, Venereology, and Leprology, 392-392.

Soltanipour, F., Delaram, M., Taavoni, S., & Haghani, H. (2014). The effect of olive oil and the Saj® cream in prevention of striae gravidarum: A randomized controlled clinical trial. Complementary Therapies in Medicine,220-225.

Ud-Din, S., D. McGeorge, and A. Bayat. "Result Filters." National Center for Biotechnology Information. U.S. National Library of Medicine, 20 Oct. 2015. Web. 12 Jan. 2016.

Valente, D., Zanella, R., Doncatto, L., & Padoin, A. (2014). Incidence and Risk Factors of Striae Distensae Following Breast Augmentation Surgery: A Cohort Study. PLoS ONE.

Article Sidebar

Full Article PDF Supplementary Figures
Published
Jul 6, 2018
DOI https://doi.org/10.25251/skin.2.4.1

Article Details

How to Cite
Moy, S., Moy, L. S., & Lesser, T. (2018). Striae Cream with Regenetrol Complex(TM) Demonstrates Efficacy on Stretch Marks: A Double-Blind Controlled Study. SKIN The Journal of Cutaneous Medicine, 2(4), 207–213. https://doi.org/10.25251/skin.2.4.1
Issue
Vol. 2 No. 4 (2018)
Section
Original Research
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.